泌尿科补充剂市场机会、成长驱动因素、产业趋势分析及预测（2026-2035年）

2025 年全球泌尿科补充剂市场价值为 22 亿美元，预计到 2035 年将以 8.2% 的复合年增长率增长至 49 亿美元。

市场成长得益于泌尿系统疾病负担的加重、人们对前列腺健康的日益关注以及消费者对积极自我保健的日益重视。数位零售平台的普及和消费者对天然配方产品的强烈偏好进一步强化了市场需求。消费者越来越倾向于寻求以科学为基础的非药物解决方案，以支持泌尿系统功能、摄护腺健康、肾臟功能以及整体泌尿系统平衡。感染率的上升、人口老化加剧以及人们向预防性和自我管理型医疗保健的转变，持续扩大潜在消费群。业界领导者凭藉先进的配方技术、经验证的植物科学以及涵盖实体零售、线上平台和专业服务管道的多元化分销策略展开竞争。持续的创新和不断加强的消费者教育措施正在增强消费者对泌尿系统膳食补充剂的信心，并支持市场的持续发展。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

• 产业生态系分析
• 产业影响因素
  • 成长驱动因素
    • 泌尿系统疾病发生率不断上升
    • 产品配方和输送系统的进步
    • 越来越重视预防性医疗保健
  • 产业陷阱与挑战
    • 潜在的相互作用和副作用
  • 市场机会
    • 对个人化营养解决方案的需求不断增长
    • 新兴市场渗透率不断提高
• 成长潜力分析
• 监管环境
  • 北美洲
  • 欧洲
  • 亚太地区
• 技术进步
  • 当前技术趋势
    • 先进的吸收和生物利用度技术
    • 用于泌尿系统健康的新型草药和功能性成分
    • 人工智慧辅助的个人化剂量和补充剂指导
  • 新兴技术
    • 机器学习在多成分配方优化的应用
    • 与可穿戴和远端健康监测设备的集成
    • 智慧封装与控释递送系统
• 差距分析
• 波特的分析
• PESTEL 分析
• 未来市场趋势
  • 基于基因和生活方式资料的个人化营养解决方案
  • 经实证医学验证、临床测试的泌尿科补充剂组合
  • 以数位优先的平台，结合人工智慧推荐和全球电子商务覆盖范围

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
  • 全球的
  • 北美洲
  • 欧洲
  • 亚太地区
• 竞争定位矩阵
• 主要市场参与者的竞争分析
• 关键进展
  • 併购
  • 合作伙伴关係与合作
  • 新产品发布
  • 扩张计划

第五章：市场估算与预测：依类型划分，2022-2035年

• 多重成分
• 单一成分

第六章：市场估算与预测：依应用领域划分，2022-2035年

• 泌尿道感染
• 摄护腺健康
• 肾臟健康
• 膀胱健康

第七章：市场估价与预测：依配方划分，2022-2035年

• 胶囊
• 软胶囊
• 片剂
• 粉末
• 其他配方

第八章：市场估算与预测：依配销通路划分，2022-2035年

• 传统实体店
• 电子商务

第九章：市场估计与预测：依地区划分，2022-2035年

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• Amway
• Better Being
• Biotexlife
• dsm-firmenich
• Himalaya Wellness
• Himalayan Organics
• Natrol
• Nature's Bounty
• Nestle
• NOW Foods
• Puritan's Pride
• Solaray
• Szio+
• Theralogix
• ZAHLER

The Global Urology Supplements Market was valued at USD 2.2 billion in 2025 and is estimated to grow at a CAGR of 8.2% to reach USD 4.9 billion by 2035.

Market growth is supported by the rising burden of urinary health disorders, growing concern around prostate wellness, and increasing consumer focus on proactive self-care routines. Wider access to digital retail platforms and a strong preference for naturally derived formulations further reinforce demand. Consumers are increasingly seeking science-backed, non-pharmaceutical solutions that support urinary tract function, prostate health, kidney performance, and overall urological balance. Rising infection rates, a growing aging population, and the shift toward preventive and self-managed healthcare continue to expand the addressable consumer base. Leading industry participants compete through advanced formulation expertise, validated botanical science, and diversified distribution strategies spanning physical retail, online platforms, and practitioner-focused channels. Continuous innovation and growing consumer education initiatives are strengthening confidence in urology-focused dietary supplementation and supporting sustained market development.

Key manufacturers emphasize high-grade ingredient sourcing, sustained research investment, and transparent consumer communication to reinforce credibility and product effectiveness. Strategic advancements centered on optimized nutrient combinations, clinically aligned formulations, and evidence-supported performance benchmarks are raising quality standards across the market and improving long-term urinary wellness outcomes.

The multi-ingredient formulations segment accounted for a 70.4% share in 2025. This leadership position reflects increasing consumer preference for all-in-one products designed to address multiple urological health needs in a single regimen. These formulations integrate diverse functional components to deliver enhanced convenience, broader health coverage, and improved perceived effectiveness, which continues to support segment growth.

The urinary tract health segment held a 67.8% share in 2025 and is projected to reach USD 3.4 billion during 2026-2035, attributed to widespread prevalence across age groups and heightened awareness of preventive nutritional approaches that support long-term urinary function and reduce recurrence risks.

North America Urology Supplements Market held a 40.2% share in 2025. Strong consumer awareness, well-established healthcare infrastructure, and rising incidence of urological conditions have fueled demand for supportive supplementation. Ongoing advances in formulation technologies and increased availability of clinically positioned products continue to accelerate regional adoption.

Prominent companies operating in the Global Urology Supplements Market include NOW Foods, Himalaya Wellness, Nestle, Natrol, Amway, Better Being, dsm-firmenich, Theralogix, Puritan's Pride, Himalayan Organics, Nature's Bounty, Solgaray, Biotexlife, ZAHLER, and Szio+. Companies in the Global Urology Supplements Market adopt targeted strategies to strengthen their competitive positioning and expand market share. Product differentiation through clinically aligned formulations and premium ingredient sourcing remains a central focus. Manufacturers invest heavily in research to support efficacy claims and meet evolving regulatory expectations. Expansion across omnichannel distribution models enables brands to reach both direct consumers and healthcare-influenced buyers. Strategic acquisitions and partnerships support portfolio diversification and geographic reach.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Type trends
  • 2.2.3 Application trends
  • 2.2.4 Formulation trends
  • 2.2.5 Distribution channel trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of urological disorders
    • 3.2.1.2 Advancements in product formulations and delivery systems
    • 3.2.1.3 Increasing emphasis on preventive healthcare
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Potential interactions and side effects
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expanding demand for personalized nutrition solutions
    • 3.2.3.2 Rising penetration across emerging markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
    • 3.5.1.1 Advanced absorption and bioavailability technologies
    • 3.5.1.2 Novel herbal and functional ingredients for urinary health
    • 3.5.1.3 AI-assisted personalized dosing and supplement guidance
  • 3.5.2 Emerging technologies
    • 3.5.2.1 Machine learning for multi-ingredient formulation optimization
    • 3.5.2.2 Integration with wearable and remote health monitoring devices
    • 3.5.2.3 Smart encapsulation and controlled-release delivery systems
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
  • 3.9.1 Tailored nutrition solutions based on genetic and lifestyle data
  • 3.9.2 Evidence-backed, clinically tested urology supplement combinations
  • 3.9.3 Digital-first platforms combining AI recommendations with global e-commerce reach

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Multi ingredient
• 5.3 Single ingredient

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Urinary tract infections
• 6.3 Prostate health
• 6.4 Kidney health
• 6.5 Bladder health

Chapter 7 Market Estimates and Forecast, By Formulation, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Capsules
• 7.3 Softgels
• 7.4 Tablets
• 7.5 Powder
• 7.6 Other formulations

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Brick & mortar
• 8.3 E-commerce

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Amway
• 10.2 Better Being
• 10.3 Biotexlife
• 10.4 dsm-firmenich
• 10.5 Himalaya Wellness
• 10.6 Himalayan Organics
• 10.7 Natrol
• 10.8 Nature's Bounty
• 10.9 Nestle
• 10.10 NOW Foods
• 10.11 Puritan's Pride
• 10.12 Solaray
• 10.13 Szio+
• 10.14 Theralogix
• 10.15 ZAHLER